SMBC Venture Capital

SMBC Venture Capital is the corporate venture capital arm of Sumitomo Mitsui Banking Corporation (SMBC), a subsidiary of Sumitomo Mitsui Financial Group (SMFG) - Japan's second-largest bank by assets. With over 1,100 investments made since its 2010 rebranding and 134 IPO exits, SMBC VC is the most active corporate VC in Japan and one of the most prolific in Asia. Understanding treasury management and cash flow is valuable for any founder.

Unlike most corporate VCs that invest opportunistically, SMBC Venture Capital runs a dedicated, continuous investment program. It manages capital directly deployed by SMBC Group, giving it consistent firepower year after year. In 2025, it launched the $300 million SMBC Fin Atlas Beyond Fund in partnership with Fin Capital specifically to invest in U.S. early-stage fintech and AI startups - a significant strategic shift toward global deal flow.

The firm sits at a unique intersection: the deal flow and speed of a professional VC with the strategic resources of one of Japan's largest financial institutions. For founders seeking more than capital - particularly those targeting banking, enterprise software, healthcare, or cross-border expansion between the U.S. and Asia - SMBC VC is one of the most consequential investors to know.

This guide covers SMBC Venture Capital's actual investment thesis, real portfolio companies, typical check sizes, stage preferences, and firm-specific strategies for getting a meeting.

SMBC Venture Capital invests in innovative startups with high growth potential, primarily in Japan but increasingly internationally through funds like the SMBC Fin Atlas Beyond Fund Understanding net revenue retention benchmarks helps founders navigate this. The firm's investment thesis is built around three core ideas: large market opportunity, strategic fit with SMBC Group's ecosystem, and the ability to add value beyond capital.

The firm evaluates opportunities across four primary sectors. IT and enterprise software represent 31% of the portfolio, encompassing everything from B2B SaaS to infrastructure tools. Services make up 39% - the largest share - spanning consumer internet, marketplace models, and business services. Life sciences accounts for 12% and is a deliberate focus area given SMBC's banking relationships across Japan's major healthcare institutions. Manufacturing and hardware make up 14%, reflecting Japan's industrial base and the firm's access to manufacturing ecosystem connections.

SMBC VC's investment thesis is distinct from pure financial VCs because it explicitly seeks companies that can benefit from SMBC Group's banking network. This includes introductions to corporate clients, potential pilot programs with SMBC's vast client base of Japanese enterprises, and access to capital markets expertise as companies scale toward IPO. The firm's 134 IPO exits - spanning everyone from base hits like BASE and Chatwork to large outcomes like GMO Internet and gumi - demonstrate it has the operational expertise to take companies all the way to public markets.

The firm also runs a dedicated seed-stage program and has maintained a consistent allocation to early-stage companies (36% of portfolio), making it relevant for founders even at Series A. The 2023 Global Brain partnership (JPY 30 billion fund for Japanese unicorns) and 2025's U.S. fintech fund show the firm is willing to deploy significant capital into growth-stage opportunities when the strategic logic is clear.

A key tenet of SMBC VC's approach is helping portfolio companies leverage Japan's largest banking network. For foreign startups, this is particularly valuable: SMBC's corporate banking relationships give portfolio companies distribution access, customer relationships, and credibility with Japanese enterprise buyers that would be nearly impossible to build from scratch.

SMBC Venture Capital has maintained a high investment tempo in recent years, completing approximately 40 new investments per year. The firm's portfolio spans all stages from seed through growth equity, with a deliberate mix of early and middle-stage commitments. Understanding NRR and why top quartile exceeds 120% is valuable for any founder.

In July 2025, SMBC launched the $300 million SMBC Fin Atlas Beyond Fund in partnership with Fin Capital, targeting U.S.-based early-stage fintech and AI companies. The fund has a 10-year duration and is structured to provide a bridge for American startups to access SMBC's Asian banking network, corporate clients, and potential strategic partnerships. This is a meaningful expansion of SMBC VC's traditionally Japan-centric approach and signals appetite for cross-border deals.

In 2023, SMBC co-launched a JPY 30 billion (approximately $210 million) fund with Tokyo-based VC firm Global Brain specifically to create Japanese unicorns. The fund focuses on late-seed through Series B companies in sectors including AI, fintech, SaaS, and life sciences. This is the largest single fund initiative SMBC VC has undertaken and reflects the firm's ambition to move beyond incremental early-stage investing into meaningful growth-equity sized checks.

On the domestic Japan side, SMBC Edge - an earlier-stage investment initiative - deployed approximately JPY 3 billion into five startups in its initial allocation, targeting deep tech and industrial innovation companies. The firm has also been active in life sciences, with investments in regenerative medicine (Heartseed), space technology (Astroscale HD), and drug discovery platforms.

Notably, SMBC VC has maintained investment activity through market cycles. Even in years where VC markets contracted, SMBC continued deploying capital as a corporate VC with patient, stable capital - a key differentiator versus independent VC funds that face LP pressure to slow down during downturns.

SMBC Venture Capital's portfolio includes 394 active investments and 134 IPO exits since 2010, making it one of Japan's most prolific investors. The portfolio spans every major technology sector, with several notable publicly traded and unicorn-stage companies.

Astroscale HD is one of SMBC VC's most prominent portfolio companies. The Tokyo-based space debris removal company went public on the Tokyo Stock Exchange and has become a category leader in orbital maintenance and debris mitigation - a critical need as low-Earth orbit becomes increasingly congested. SMBC VC's banking network provided meaningful support in Astroscale's enterprise and government customer development.

Heartseed is a regenerative medicine company focused on cellular therapy for heart disease. The firm's scientific approach to心肌再生 has attracted significant pharmaceutical partnership interest and represents SMBC VC's deliberate push into life sciences where Japanese corporate networks create meaningful deal support.

In the financial technology space, the portfolio includes companies that went public on NASDAQ (Pixie Dust Tech), as well as established SaaS businesses like SmartDrive (fleet management technology), note (fintech), and Cover (insurance tech). These exits demonstrate SMBC VC's ability to identify opportunities in sectors where banking relationships create direct value.

Other notable publicly traded portfolio companies include Veritas In Silico (biotech/ drug discovery AI), QPS研究所 (pharma research services), Meek (e-commerce infrastructure), Schoo (online education), and ROXX (HR tech). The breadth of sectors reflects SMBC VC's thesis-agnostic approach to identifying category leaders regardless of vertical.

Earlier-stage holdings include Illumi Medical (therapeutic medical devices), Qubitcore (quantum computing hardware), and Monochrome Company (consumer/subculture tech). These represent the firm's willingness to invest at Series A in ambitious teams attacking large problems.

The portfolio's diversity - spanning enterprise software, consumer internet, fintech, life sciences, space tech, and industrial hardware - reflects SMBC VC's core conviction that Japan's entrepreneurial ecosystem has breadth beyond the country's stereotype as a hardware-centric economy.

SMBC Venture Capital evaluates investments based on four core criteria: team quality, market size, strategic fit with SMBC Group, and ability to demonstrate traction.

Team quality is evaluated with particular emphasis on domain expertise and the ability to attract talent. SMBC VC partners have noted that founders with prior operating experience at major Japanese corporations or successful serial entrepreneurs tend to advance further in the process. The firm looks for evidence that the team can execute, not just ideate.

Market size matters significantly. SMBC VC prefers companies addressing markets large enough to support a JPY 100 billion+ valuation (approximately $700 million+) over a five-to-seven-year horizon. This means founders should be able to articulate a credible path to significant market share in a market with clear scale economics.

Strategic fit with SMBC Group is unique to corporate VCs and is often decisive. SMBC VC asks explicitly: can this company benefit from access to SMBC's corporate banking clients, treasury relationships, or distribution network? Founders who can articulate a concrete pipeline of SMBC-driven customer opportunities - not just vague 'banking network' value - have a meaningful advantage.

Traction metrics required depend on stage but typically include some evidence of product-market fit: revenue growth, retention rates, customer acquisition costs, or in life sciences, regulatory progress. Early-stage companies without revenue should demonstrate meaningful user growth, engagement metrics, or partnership traction.

Geographic positioning is increasingly relevant. With the Fin Atlas Beyond Fund specifically targeting U.S. fintech companies, and the Global Brain partnership targeting Japanese companies with global potential, SMBC VC is interested in founders who think internationally. Japanese market founders should articulate their Asia expansion strategy; U.S. founders should articulate what SMBC's banking network unlocks that their existing investors cannot.

The most effective path to SMBC VC is through warm introductions from portfolio company founders, other institutional investors, or advisors who have worked with the firm. SMBC VC partners actively source deal flow through their network of Japanese corporate executives and banking relationship managers, so referrals from these channels carry significant weight.

For U.S. fintech companies targeting the Fin Atlas Beyond Fund specifically, the partnership with Fin Capital provides an additional entry point. Fin Capital's U.S. venture network and LP relationships give founders an alternative to approaching SMBC VC directly. The fund is structured to be founder-friendly and operates with more speed and flexibility than a typical corporate VC.

Cold outreach to SMBC VC works best when three conditions are met: the company is in a sector on SMBC VC's investment list (IT, services, life sciences, manufacturing), there is a clear strategic angle connecting the company to SMBC Group's banking ecosystem, and the company has metrics that indicate strong momentum ( ARR benchmarks growth, large raise already secured from credible investors, or meaningful enterprise traction).

When preparing your pitch for SMBC VC, lead with the problem you are solving and your solution's differentiation. The investment committee will challenge your market size assumptions and competitive positioning. Be specific: not just 'we compete with incumbents' but 'here is exactly why we win against X, Y, and Z alternatives and here is the evidence.'

SMBC VC's due diligence process for a typical investment takes four to eight weeks from initial meeting to term sheet, though it can move faster for seed-stage opportunities or when strategic urgency is high. Expect multiple conversations with different partners, a detailed financial review, and reference calls with existing customers or partners.

Follow-up discipline matters. SMBC VC partners see many companies and processes multiple referrals simultaneously. Send concise updates on milestones, new customer wins, or financing activity. Avoid being pushy - the firm's investment committee process takes the time it takes - but stay visible with relevant news.

Even if your current round does not result in investment, building a relationship with SMBC VC is valuable for the long term. The firm often participates in follow-on rounds for portfolio companies and may be relevant in future raises. For Japanese marketentry strategies, maintaining SMBC VC as a contact provides insight into what large Japanese enterprises are prioritizing.

While SMBC Venture Capital invests in early-stage companies, they expect founders to have a solid command of their business's financial mechanics. For Series A and later companies, this includes clean cap tables, investor-ready financial statements, and realistic financial models.

Japanese corporate VCs in particular scrutinize financial projections more heavily than their U.S. counterparts. SMBC VC's investment committee will probe your assumptions on customer acquisition cost, lifetime value, path to profitability, and how you plan to use the capital you raise. Founders who cannot explain their SaaS unit economics in granular detail lose credibility quickly.

For foreign companies approaching the Fin Atlas Beyond Fund, prepare U.S.-style pitch materials but also be ready to discuss international expansion economics and how Japanese market entry would affect your margin profile. SMBC VC will want to understand your capital efficiency and whether you can sustain investment across two market contexts simultaneously.

Working with a fractional CFO is especially valuable when raising from corporate VCs like SMBC VC. The firm evaluates hundreds of companies per year; having professional-grade financial projections, data rooms, and board-level metrics ready to go signals that you are further along in operational maturity than typical early-stage companies.

Financial preparedness extends beyond the fundraise itself. SMBC VC's best portfolio companies maintain rigorous financial discipline as they scale, which is what allows them to navigate the public markets process when they reach IPO. Demonstrating this discipline early - even at seed stage - is a signal of long-term category leadership.

Whether you are raising from SMBC Venture Capital or any other institutional investor, having professional-grade financials, a realistic model, and a clear use-of-funds narrative sets you apart from the majority of companies pitching. Our team has helped dozens of startups prepare for conversations with Japanese corporate VCs and understand what the investment committee looks for in a financial presentation.

Researching other venture capital firms? Our comprehensive collection of VC firm reviews covers corporate VCs, independent funds, and growth equity investors across all stages and sectors.

Each review provides detailed, firm-specific information about investment criteria, actual portfolio companies, check sizes, and strategies for getting a meeting. Whether you are raising a seed round in Tokyo or a growth round from a U.S. corporate VC, our guides help you approach the right investors with the right narrative.

Finding the right investor for your company depends heavily on strategic fit - not just sector and stage, but whether the firm can actually help you build the business you are trying to create. Take time to understand each investor's portfolio thesis and network before reaching out.